Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002964 · ClinicalTrials.gov registry record · Phase 2
Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002964 is a Phase 2 study that has completed, run by Roswell Park Cancer Institute.
The verdict
NCT00002964, a Phase 2 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs that make cancer cells more visible to light may help in the diagnosis of head and neck cancer. PURPOSE: Phase II trial to study the usefulness of porfimer sodium in diagnosing patients with head and neck cancer.
Interventions
- DRUG porfimer sodium
- OTHER fluorophotometry
Trial Details
| Field | Value |
|---|---|
| Start Date | 1995-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002964
The ClinicalTrials.gov registry entry for NCT00002964 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which porfimer sodium is the first listed.
NCT00002964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002964 about?
NCT00002964 is a clinical study titled "Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer". RATIONALE: Drugs that make cancer cells more visible to light may help in the diagnosis of head and neck cancer. PURPOSE: Phase II trial to study the usefulness of porfimer sodium in diagnosing patients with head and neck cancer.
What is the current status of trial NCT00002964?
This trial is currently completed. It is a Phase 2 study. The study started on 1995-02.
What interventions are being tested in trial NCT00002964?
The interventions under investigation include: porfimer sodium (DRUG), fluorophotometry (OTHER).
Who is sponsoring clinical trial NCT00002964?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.